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Operative Management of Carotid Artery In-stent Restenosis:
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Objectives: Carotid Artery Stenting (CAS) may be comparable to Carotid Endarterectomy (CEA) as a durable and
effective procedure in stroke prevention. Concern remains about the incidence of restenosis after stenting and its
management. We evaluated the surgical managment of restenosis after CAS.
Design: prospective study.
Methods: between December 1997 and April 2001, 217 CAS procedures were performed in 217 patients (155 men and 62
women; age 70 years+ 8.2). After a mean of 8 months post-stenting four patients (two symptomatic, two asymptomatic
with contralateral occlusion) with severe haemodynamic in-stent restenosis (90±99%) had surgical reintervention.
Results: standard CEA with removal of the stent was performed in all four patients. No major complications occurred.
Intima hyperplasia showed to be the predominant mechanism leading to in-stent restenosis. All four surgically treated
patients remained asymptomatic and without recurrent restenosis over a mean follow-up time of 13 months (range 3±20
months).
Conclusion: the optimal treatment of in-stent restenosis has yet to be defined, but standard CEA with removement of the
stent appears to be feasible.
Key Words: Restenosis; CEA; CAS; Histology.
Introduction
Carotid artery stenting (CAS) may be comparable to
CEA as a durable and effective procedure in stroke
prevention.1,2 The use of percutaneous carotid angio-
plasty, first reported in 19813 was initially limited as a
result of issues surrounding possible embolic compli-
cations, suboptimal angiographic results, acute vessel
closure, elastic recoil, and restenosis. In the last dec-
ade, however, the introduction of adjunctive stenting
has mitigated many of these concerns. Although still
an emerging technique using evolving equipment,
both single-center reports2,4±6 and worldwide
surveys7 of carotid stenting have demonstrated pro-
cedural results appoaching those of endarterectomy,
typically in the high-risk patient with significant
comorbidities excluded from the previous surgical
trials.8,9 Complications of anaesthesia, infection,
haemorrhage, myocardial infarction, and cranial
nerve palsy are avoided with stenting, which has
also shown the potential to shorten hospital stays
and lower costs compared with endarterectomy.10
However, concern remains about the incidence of rest-
enosis after stenting and its management.11 In-stent
restenosis after CAS has been reported in 2±8% of
cases.2,7,12 The clinical follow-up in most of these
reports is relatively short, generally less than
12 months. Clearly long term follow studies are
needed.13
Repeat angioplasty, carotid endarterectomy, and
carotid artery reconstruction have all been used to
treat restenosis after CAS. No definitive evidence
exists concerning the optimal management of in-
stent restenosis. While little experience exists with
endovascular techniques for the management of
in-stent restenosis we present our experience with
the surgical treatment of restenosis after CAS. We
report on four consecutive patients who developed
severe in-stent restenosis, and subsequently under-
went standard carotid endarterectomy with remove-
ment of the stent and follow-up with duplex scanning.
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STENT REMOVAL CAROTID BIFURCATION
STENT
STRUTS
ICA LUMENMYOINTIMA
HYPERPLASIA
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occlusion of the carotid artery are less likely to
arise.2,14 Furthermore, stenting of coronary vessels
has been associated with significantly lower rates of
angiographic and clinical restenosis than angioplasty
alone.15 Myointimal hyperplasia with smooth muscle
cell proliferation is the predominant mechanism lead-
ing to in-stent restenosis16,17 as well as the underlying
mechanism for restenosis occurring within 2±3 years
of CEA.18,19 Unlike carotid endarterectomy, stenting
does not remove the atheromatous plaque, and the
insertion of a stent causes vascular injury. Although
angiographic studies have indicated that in coronary
arteries restenosis in stents with a central articulation
occurs more frequently at the articulation,20 in a serial
intravascular study neointimal tissue proliferation
tended to be uniformly distributed over the length of
the stent.21 However, the determinants and biological
basis of the response to stent imposed injury are not
yet understood. The focal deep trauma of expanding
struts, extensive early thrombus within days of stent-
ing, permanent strain to the vessel wall, and foreign
material remaining in the injured artery all seem to
play a role.22,23 From experimental models the con-
struction of stents causing less vascular injury seems
promising.24
Repeat angioplasty, carotid endarterectomy, and
carotid artery reconstruction have all been used to
treat restenosis after CAS.25±28 Recently one case has
been described with deployment of a stent within a
stent.29 No definitive evidence exists concerning the
optimal management of in-stent restenosis. The first
case of CEA after CAS was reported by Vale et al.30
Their patient experienced a 50% restenosis of the
treated segment 6 months after stent deployment.
Reedy et al. described successful stent removal in
two patients without complications until hospital
discharge but without histology or follow-up.31 In
his 5-year follow-up study Roubin et al.9 only
mentioned one patient to require CEA for restenosis
and no details were given. In their series 16 patients
(3%) required repeated angioplasty for restenosis.
Uncomplicated stent removal for a less common com-
plication such as detachment and distortion of the
stent (both Palmaz stents) also has been reported.32,33
So far no cases of stent removal resulting in major
complications have been reported, although several
authors do point at the technical difficulty of the pro-
cedure. Exposure of the carotid artery can be particu-
larly difficult because of scarring and the need to
access the artery proximal and distal to the stent
containing segment.26,30 Furthermore, inflammation
of the carotid bifurcation can make the procedure
more complicated. The inflammatory reaction within
the stented artery causes the stent to become adherent
to the arterial wall making identification of the endar-
terectomy plane hardly possible.27 In the four proce-
dures we performed no inflammation was noted and
the traditional cleavage plane in the intima/media
layer was well recognizable and accessible.
Carotid stenting brings significantly lower cost and
resource utilization compared with CEA.10 In an
analogous comparison, studies of percutaneous angio-
plasty versus bypass surgery in patients with multi-
vessel coronary disease have found significantly
greater hospital costs associated with the surgical
pathway but nearly equivalent costst at 5 years, largely
because of the repeated intervention required in the
angioplasty arm secondary to a significant rate of cor-
onary restenosis.34 Also if experience from superficial
femoral and iliac artery stenting is considered, the
early results of CAS must be tempered by develop-
ment of late complications requiring secondary inter-
vention and thus more overall costs. There is an
important need to establish the efficacy, safety, and
durability of carotid stenting by comparison with sur-
gery, before the technique is widely introduced.
Conclusion
The optimal treatment of in-stent restenosis has yet to
be defined, but standard CEA with removement of the
stent appears to be feasible and should be considered
as an alternative when recurrent stenosis occurs after
CAS. At short term follow-up, no restenosis occurs in
the stent removed area, and so far the removal of a
carotid stent in combination with a classic endarter-
ectomy seems to be a durable procedure. All four
patients with CEA after CAS remained asymptomatic
and without recurrent restenosis with a mean follow-
up of more than 1 year. Of course long term follow-up
has to be awaited.
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